相关实验视频

Updated: Jan 14, 2026

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach

Published on: June 5, 2010

在异形性炎症性肌肉病变中出现的新疗法

Merve Kocyigit^1,2,3, Jan Piet van Hamburg^2,3, Eleonora Aronica⁴

¹Department of Neurology, Amsterdam Neuroscience, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.

Journal of neuromuscular diseases

|October 23, 2025

概括

异常性炎症性肌肉病变 (IIM) 是一种导致肌肉炎症的自身免疫性疾病. 新的研究探索了针对IIM复杂机制的新疗法,为改善患者的治疗结果提供了希望.

科学领域:

免疫学免疫学免疫学
类风湿病学类风湿病学
自免疫性疾病自免疫性疾病

背景情况:

异常性炎症性肌肉病变 (IIM),或肌肉炎,是一种罕见的自身免疫性疾病,导致肌肉和肌肉外炎症.
目前对IIM的治疗缺乏强有力的证据,许多患者经历了持续的疾病活动和生活质量的降低,尽管治疗.
在IIM管理中的挑战包括疾病异质性,罕见发生,系统性参与和对病原体的有限理解.

研究的目的:

审查IIM的免疫病原发生,包括自身抗体,B细胞,T细胞,干扰素通路和补充的作用.
讨论IIM目前的治疗策略.
为IIM提供新兴和有前途的新型治疗方法的概述.

主要方法:

对IIM免疫病原发生和治疗的现有文献的审查.
对新型IIM疗法的最近和正在进行的临床试验的分析.
讨论IIM背后的分子和细胞机制.

主要成果:

最近的见解已经确定了IIM的新型治疗点.
新兴的治疗方法包括CAR T细胞疗法,T细胞参与剂,FcRn抑制剂和小分子抑制剂 (JAKs,IFN,补充剂).
了解IIM病原体对于开发有效疗法至关重要.

结论:

尽管面临挑战,但了解IIM病变的进展正在为向治疗铺平道路.
新的治疗方法有望改善患有异常性炎症肌肉病的患者的治疗结果.
进一步的研究和临床试验对于验证IIM的新治疗方法至关重要.

关键词:

新兴的治疗方法.异形性炎症性肌肉病变 (Idiopathic Inflammatory Myopathy) 是一种异形性炎症性肌肉病变 (Idiopathic Inflammatory Myopathy) 是一种异形性炎症性肌肉病变.肌肉性肌肉性炎症肌肉性肌肉炎病变的发生和发病.治疗治疗治疗治疗治疗治疗

更多相关视频

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

相关概念视频

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...